Lisa Modelevsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Midwestern UniversityPharmD, 2012
Publications & Presentations
PubMed
- 4 citationsRapid infusion rituximab is well tolerated in patients with primary CNS lymphoma.Lisa Modelevsky, Richard F Tizon, Samantha N Reiss, Marcel Smith, Rachel Garonce
CNS Oncology. 2018-07-01 - 44 citationsRetrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomasSamantha N Reiss, Prakirthi Yerram, Lisa Modelevsky, Christian Grommes
Journal for Immunotherapy of Cancer. 2017-12-19
Office
1275 York Ave
New York, NY 10065Phone+1 646-888-6602Fax+1 212-639-2171
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
